CITIUS ONCOLOGY, INC. (CTOR) › Shareholders' EquityCITIUS ONCOLOGY, INC. (CTOR) — Shareholders' EquityAnnual figures by period end, from SEC filings.2021-12-31: -$10.1K2022-09-30: $36.27M2022-12-31: $345.5K2023-09-30: $25.54M2023-12-31: -$1.99M2024-09-30: $46.14M2025-09-30: $44.87M$44.87M2021-12-31Shareholders' Equity (USD)2025-09-30Period endedShareholders' EquityChange YoYSource filing2025-09-30$44.87M-2.8%2025-12-23Balance as of period end2024-09-30$46.14M—2025-12-23Balance as of period end2023-12-31-$1.99M—2024-04-16Balance as of period end2023-09-30$25.54M—2025-12-23Balance as of period end2022-12-31$345.5K—2024-04-16Balance as of period end2022-09-30$36.27M—2024-12-27Balance as of period end2021-12-31-$10.1K—2024-04-16Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)